Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GOVX B11

Next Previous
X
Search
Drug Profile

GOVX B11

Alternative Names: DNA/MVA; DNA/MVA-unadjuvanted-vaccine; GEO-D02 DNA vaccine; GEO-D03 DNA vaccine; GeoVax Clade B DNA/MVA HIV/AIDS Vaccine; GeoVax-Clade-B-DNA/MVA-HIV/AIDS-unadjuvanted-vaccine; GOVX B01; pGA2-JS7 + MVA/HIV62

Latest Information Update: 19 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GeoVax Labs; National Institute of Allergy and Infectious Diseases
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 13 Feb 2024 GeoVax Labs receives patent protection for Multivalent HIV Vaccine Boost Compositions and Methods of Use
  • 05 Oct 2023 GeoVax Labs receives a Notice of Allowance for Multivalent HIV Vaccine Boost Compositions and Methods of Use
  • 22 Apr 2022 GOVX B11 is available for licensing as of 22 Apr 2022. www.geovax.com

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top